| Tretinoin | Approved Investigational Nutraceutical | SFRP2 | 6423 |
downregulated | Tretinoin results in decreased expression of SFRP2 mRNA | 4q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SFXN2 | 118980 |
downregulated | Tretinoin results in decreased expression of SFXN2 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | SGCB | 6443 |
downregulated | Tretinoin results in decreased expression of SGCB mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | SGCD | 6444 |
upregulated | Tretinoin results in increased expression of SGCD mRNA | 5q33.2-q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SGIP1 | 84251 |
upregulated | Tretinoin results in increased expression of SGIP1 mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SGK1 | 6446 |
upregulated | Tretinoin results in increased expression of SGK1 mRNA | 6q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SGK3 | 23678 |
upregulated | Tretinoin results in increased expression of SGK3 mRNA | 8q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SGTB | 54557 |
downregulated | Tretinoin results in decreased expression of SGTB mRNA | 5q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SH2B3 | 10019 |
upregulated | Tretinoin results in increased expression of SH2B3 mRNA | 12q24.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SH2D5 | 400745 |
downregulated | Tretinoin results in decreased expression of SH2D5 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3BGRL3 | 83442 |
upregulated | Tretinoin results in increased expression of SH3BGRL3 mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3BP2 | 6452 |
downregulated | Tretinoin results in decreased expression of SH3BP2 mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3BP4 | 23677 |
downregulated | Tretinoin results in decreased expression of SH3BP4 mRNA | 2q37.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3BP5 | 9467 |
upregulated | Tretinoin results in increased expression of SH3BP5 mRNA | 3p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3BP5L | 80851 |
upregulated | Tretinoin results in increased expression of SH3BP5L mRNA | 1q44 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3D19 | 152503 |
downregulated | Tretinoin results in decreased expression of SH3D19 mRNA | 4q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3GLB1 | 51100 |
upregulated | Tretinoin results in increased expression of SH3GLB1 mRNA | 1p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3PXD2A | 9644 |
upregulated | Tretinoin results in increased expression of SH3PXD2A mRNA | 10q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3RF3 | 344558 |
upregulated | Tretinoin results in increased expression of SH3RF3 mRNA | 2q13 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3TC2 | 79628 |
upregulated | Tretinoin results in increased expression of SH3TC2 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | SH3YL1 | 26751 |
upregulated | Tretinoin results in increased expression of SH3YL1 mRNA | 2p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SHANK2 | 22941 |
downregulated | Tretinoin results in decreased expression of SHANK2 mRNA | 11q13.3-q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | SHANK2 | 22941 |
upregulated | Tretinoin results in increased expression of SHANK2 mRNA | 11q13.3-q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | SHD | 56961 |
upregulated | Tretinoin results in increased expression of SHD mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SHE | 126669 |
upregulated | Tretinoin results in increased expression of SHE mRNA | 1q21.3 | |